NWS
ABBV icon

Newport Wealth Strategies’s AbbVie ABBV Stock Holding History

Newport Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$268K Sell
2,487
-378
-13% -$43.2K 0.16% 87
2021
Q2 		$323K Buy
2,865
+2
+0.1% +$225 0.19% 82
2021
Q1 		$310K Sell
2,863
-32
-1% -$3.42K 0.19% 79
2020
Q4 		$254K Hold
2,895
– – 0.19% 72
2020
Q3 		$252K Sell
2,895
-55
-2% -$5.18K 0.19% 73
2020
Q2 		$290K Sell
2,950
-340
-10% -$29.9K 0.26% 59
2020
Q1 		$270K Buy
+3,290
New +$280K 0.25% 66

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Newport Wealth Strategies's ABBV Position: Q3 2021 in Review

Newport Wealth Strategies reduced its AbbVie (ABBV) stake by 13% in Q3 2021, selling an estimated $43.2K and leaving 2,487 shares worth $268K. The position accounts for 0.16% of the portfolio, ranked #87.

Newport Wealth Strategies first reported a position in ABBV in Q1 2020 and has held it in 7 quarters since. The position peaked at $323K in Q2 2021. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Newport Wealth Strategies held 2,487 shares of AbbVie worth $268K as of Q3 2021.
  • Newport Wealth Strategies sold 378 AbbVie shares in Q3 2021, an estimated $43.2K.
  • AbbVie made up 0.16% of Newport Wealth Strategies's portfolio in Q3 2021, its #87 holding.
  • Newport Wealth Strategies first reported a position in AbbVie in Q1 2020 and has held it in 7 quarters since.
  • Newport Wealth Strategies's AbbVie position peaked at $323K in Q2 2021.
  • 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Newport Wealth Strategies's 13F filing for Q3 2021, filed 12 Nov 2021.